top of page

Order volume available up to 4 million tests per month, 48 million annually. For high volume orders, please request a quote.

SPERA™ COVID-19 Ag Test - Carton Order (200 Tests)

SPERA™ COVID-19 Ag Test - Carton Order (200 Tests)

Excluding Sales Tax

200 individual tests per carton.  Each carton includes 20 kit boxes of 10 tests. Limit of 5 Cartons (1,000 tests) per order.


Product Description

The SPERA™ COVID-19 Antigen Test is an easy to use, high quality rapid SARS-CoV-2 antigen test with an industry leading sensitivity rate of 92% and specificity rate of 97%. FDA authorized at the point-of-care,  the SPERA™ COVID-19 Ag tests is specifically designed for high volume and efficient testing to support a safer return to schools, travel and workplaces. 


Made in Japan. Best-in-class Japanese manufacturing, the SPERA™ COVID-19 Antigen Test is a premium and highly effective test, verified to be effective against major circulating variants including the Delta variant as well as the Alpha, Beta and Gamma. 

Fast, Reliable, Effective and Affordable. The SPERA™ COVID-19 Antigen Test is an optimal testing solution for healthcare professionals who value high quality testing in outpatient clinical centers. Multiple SPERA™ COVID-19 Antigen tests can be run in parallel in small spaces without operating any complex and slow instruments while maintaining test accuracy and reliability.


Effective Against Variants

Proven to detect all known variants including Omicron, Delta and Lambda.




Tests Per Kit


Test Kits Per Carton


Total Tests Per Carton


Test Kit Dimensions (LxWxH)

7.8  x 3.8 x 3.1 Inches

Carton Dimensions (LxWxH):

 21.7 x 15.7 x 13.8 Inches

Test Kit Weight (lbs):

0.90 LBS

Carton Weight (lbs):

18 LBS


Test Kit Components

Each Test Kit Includes: 

10 COVID-19 Test Cartridges (LFIA)

10 Sterile Shallow Nasal Swabs

10 Sample Collection Tubes with buffer

10 Sample Collection Caps

Convenient Sample Collection Tube Stand

Instructions for Use (IFU)

Quick Reference Guide (QRG)

Testing Details

Collection/Analysis Location


Sample Collection

Anterior Nasal Swab

Diagnostic Target:


Time to Results:

15 Minutes

Shelf life:

12 Months

Intended Use

Qualitative detection of nucleocapsid protein antigen from SARSCoV-2 in direct anterior nasal swabs from individuals suspected of COVID-19 by their healthcare provider within the first five (5) days of symptom onset. Emergency use of this test is limited to authorized laboratories.


SPERA™ Product Documentation

In the USA, the SPERA™ COVID-19 Antigen Test has not been FDA cleared or approved; but has been authorized by FDA under an EUA for use by authorized laboratories; use by laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C §263a, that meet the requirements to perform moderate, high, or waived complexity tests. The SPERA™ COVID-19 Ag Test is authorized for use at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.


Enterprise Orders

For high volume orders please request a quote.